Please login to the form below

Not currently logged in


This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

FDA approves Apellis’ Empaveli for rare blood disease

FDA approves Apellis’ Empaveli for rare blood disease

The US Food and Drug Administration (FDA) has approved Apellis’ Empaveli for the treatment of adults with the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH), setting up a rivalry with ... As the first, FDA-approved targeted C3 therapy,

Latest news

More from news
Approximately 757 fully matching, plus 2,918 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 159 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 66 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....